{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:03:54Z","timestamp":1790787834485,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.bmc.2020.115401","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T20:22:49Z","timestamp":1582662169000},"page":"115401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Rational modifications, synthesis and biological evaluation of new potential antivirals for RSV designed to target the M2-1 protein"],"prefix":"10.1016","volume":"28","author":[{"given":"Salvatore","family":"Ferla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Manganaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Benato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine","family":"Paulissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Jochmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Brancale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Bassetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2020.115401_b0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12016-013-8368-9","article-title":"Respiratory syncytial virus \u2013 a comprehensive review","volume":"45","author":"Borchers","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.bmc.2020.115401_b0010","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/CMR.00010-16","article-title":"Respiratory syncytial virus: infection, detection, and new options for prevention and treatment","volume":"30","author":"Griffiths","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bmc.2020.115401_b0015","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/ppul.21377","article-title":"Respiratory syncytial virus prevention and therapy: past, present, and future","volume":"46","author":"Wright","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.bmc.2020.115401_b0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coph.2014.03.008","article-title":"Alternative mechanisms for respiratory syncytial virus (RSV) infection and persistence: could RSV be transmitted through the placenta and persist into developing fetal lungs?","volume":"16","author":"Piedimonte","year":"2014","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.bmc.2020.115401_b0025","first-page":"18","article-title":"New therapies for acute RSV infections: where are we?","volume":"68","author":"Xing","year":"2019","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.bmc.2020.115401_b0030","first-page":"CD000181","article-title":"Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children","volume":"24","author":"Ventre","year":"2007","journal-title":"Cochrane Data Syst Rev"},{"key":"10.1016\/j.bmc.2020.115401_b0035","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/jp.2008.28","article-title":"Prevention of hospitalization due to respiratory syncytial virus: results from the palivizumab outcomes registry","volume":"28","author":"Frogel","year":"2008","journal-title":"J Perinatol"},{"key":"10.1016\/j.bmc.2020.115401_b0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3390\/v5010211","article-title":"Respiratory syncytial virus entry inhibitors targeting the F protein","volume":"5","author":"Sun","year":"2013","journal-title":"Viruses"},{"key":"10.1016\/j.bmc.2020.115401_b0045","first-page":"1","article-title":"Assessing variation in the cost of palivizumab for respiratory syncytial virus prevention in preterm infants","volume":"2","author":"Shahabi","year":"2017","journal-title":"Pharmaco-Economics-Open"},{"key":"10.1016\/j.bmc.2020.115401_b0050","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3389\/fmicb.2019.01327","article-title":"Overview of current therapeutics and novel candidates against influenza, respiratory syncytial virus, and middle east respiratory syndrome coronavirus infections","volume":"10","author":"Behzadi","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmc.2020.115401_b0055","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/acs.jmedchem.8b01361","article-title":"State of the art in respiratory syncytial virus drug discovery and development","volume":"62","author":"Cockerill","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115401_b0060","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1099\/0022-1317-79-9-2221","article-title":"Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community","volume":"79","author":"Peret","year":"1998","journal-title":"J Ge Virol"},{"key":"10.1016\/j.bmc.2020.115401_b0065","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/viro.2001.1105","article-title":"Synergistic effects of gene-end signal mutations and the M2\u20131 protein on transcription termination by respiratory syncytial virus","volume":"288","author":"Sutherland","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.bmc.2020.115401_b0070","doi-asserted-by":"crossref","first-page":"6363","DOI":"10.1128\/JVI.00335-09","article-title":"The respiratory syncytial virus M2\u20131 protein forms tetramers and interacts with RNA and P in a competitive manner","volume":"83","author":"Tran","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2020.115401_b0075","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1128\/JVI.74.13.5880-5885.2000","article-title":"The Cys3-His1 motif of the respiratory syncytial virus M2\u20131 protein is essential for protein function","volume":"74","author":"Hardy","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2020.115401_b0080","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1128\/JVI.03488-14","article-title":"Zinc binding activity of human metapneumovirus M2\u20131 protein is indispensable for viral replication and pathogenesis in vivo","volume":"89","author":"Cai","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.bmc.2020.115401_b0085","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1128\/AAC.01671-09","article-title":"Inhibition of HIV-1 replication by a bis-thiadiazolbenzene-1,2-diamine that chelates zinc ions from retroviral nucleocapsid zinc fingers","volume":"54","author":"Pannecouque","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2020.115401_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-7-20","article-title":"Inactivation of respiratory syncytial virus by zinc finger reactive compounds","volume":"7","author":"Boukhvalova","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.bmc.2020.115401_b0095","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1073\/pnas.1317262111","article-title":"Crystal Structure of the essential transcription antiterminator M2\u20131 protein of human respiratory syncytial virus and Implications of its phosphorylation","volume":"111","author":"Tanner","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2020.115401_b0100","doi-asserted-by":"crossref","first-page":"e01554","DOI":"10.1128\/mBio.01554-18","article-title":"The structure of the human respiratory syncytial virus M2\u20131 protein bound to the interaction domain of the phosphoprotein P defines the orientation of the complex","volume":"9","author":"Selvaraj","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.bmc.2020.115401_b0105","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.antiviral.2015.08.003","article-title":"In silico structure-based design and synthesis of novel anti-RSV compounds","volume":"122","author":"Cancellieri","year":"2015","journal-title":"Antivir Res"},{"key":"10.1016\/j.bmc.2020.115401_b0110","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bmcl.2009.11.071","article-title":"Fluconazole analogues containing 2H\u20131,4-benzothiazin-3(4H)-one or 2H\u20131,4-benzoxazin-3(4H)-one moieties, a novel class of anti-Candida agents","volume":"20","author":"Borate","year":"2010","journal-title":"Bioorganic Med Chem Lett"},{"key":"10.1016\/j.bmc.2020.115401_b0115","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1016\/j.tetlet.2008.03.120","article-title":"Microwave-assisted one-pot synthesis of benzo[b][1,4]oxazin-3(4H)-ones via Smiles rearrangement","volume":"49","author":"Zuo","year":"2008","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmc.2020.115401_b0120","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.bmc.2012.01.022","article-title":"Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol","volume":"20","author":"Peprah","year":"2012","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.bmc.2020.115401_b0125","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/jm900722z","article-title":"Procaspase-3 activation as an anti-cancer strategy: structure-activity relationship of procaspase-activating compound 1 (PAC-1) and its cellular co- localization with caspase-3","volume":"52","author":"Peterson","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115401_b0130","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1021\/ol401065r","article-title":"Efficient cobalt-catalyzed oxidative conversion of lignin models to benzoquinones","volume":"15","author":"Biannic","year":"2013","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2020.115401_b0135","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ejmech.2011.01.020","article-title":"Exploration of (S)-3-aminopyrrolidine as a potentially interesting scaffold for discovery of novel Abl and PI3K dual inhibitors","volume":"46","author":"Zhang","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115401_b0140","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1021\/jm201294r","article-title":"Structure-activity relationship studies of sulfonylpiperazine analogues as novel negative allosteric modulators of human neuronal nicotinic receptors","volume":"55","author":"Henderson","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115401_b0145","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1016\/j.ejmech.2010.02.008","article-title":"Synthesis, evaluation and computational studies on a series of acetophenone based 1-(aryloxypropyl)-4-(chloroaryl) piperazines as potential atypical antipsychotics","volume":"45","author":"Bali","year":"2010","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2020.115401_b0150","doi-asserted-by":"crossref","first-page":"5275","DOI":"10.1021\/ol0620141","article-title":"Straightforward and highly efficient catalyst-free one-pot synthesis of dithiocarbamates under solvent-free conditions","volume":"8","author":"Azizi","year":"2006","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2020.115401_b0155","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1016\/j.bmc.2006.07.065","article-title":"Synthesis, antimycobacterial and antitumor activities of new (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)methyl N, N- disubstituted dithiocarbamate\/O-alkyldithiocarbonate derivatives","volume":"14","author":"G\u00fczel","year":"2006","journal-title":"Bioorganic Med Chem"},{"key":"10.1016\/j.bmc.2020.115401_b0160","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1039\/C4OB00005F","article-title":"A unique dithiocarbamate chemistry during design & synthesis of novel sperm-immobilizing agents","volume":"12","author":"Jangir","year":"2014","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2020.115401_b0165","doi-asserted-by":"crossref","first-page":"e1004995","DOI":"10.1371\/journal.ppat.1004995","article-title":"Molecular basis for the selective inhibition of respiratory syncytial virus RNA polymerase by 2'-fluoro-4'-chloromethyl-cytidine triphosphate","volume":"11","author":"Deval","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bmc.2020.115401_b0170","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.1021\/acs.jmedchem.5b00258","article-title":"Applications of fluorine in medicinal chemistry","volume":"58","author":"Gillis","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2020.115401_b0175","unstructured":"Schr\u00f6dinger Release 2019-3: Maestro, Schr\u00f6dinger, LLC, New York, NY; 2019."},{"key":"10.1016\/j.bmc.2020.115401_b0180","unstructured":"Schr\u00f6dinger Release 2019-3: Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY, 2019. Maestro-Desmond Interoperability Tools, Schr\u00f6dinger, New York, NY; 2019."},{"key":"10.1016\/j.bmc.2020.115401_b0185","doi-asserted-by":"crossref","first-page":"14047","DOI":"10.1039\/C4CP01378F","article-title":"Performance of the MM\/GBSA scoring using a binding site hydrogen bond network-based frame selection: the protein kinase case","volume":"16","author":"Adasme-Carre\u00f1o","year":"2014","journal-title":"Phys Chem Chem Phys"},{"key":"10.1016\/j.bmc.2020.115401_b0190","unstructured":"Schr\u00f6dinger Release 2019-3: Prime, Schr\u00f6dinger, LLC, New York, NY; 2019."},{"key":"10.1016\/j.bmc.2020.115401_b0195","unstructured":"ULC, C. C. G. Molecular Operating Environment (MOE), 2019.10, 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7; 2019."},{"key":"10.1016\/j.bmc.2020.115401_b0200","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/jm5017279","article-title":"Discovery of 4\u2019-chloromethyl-2\u2019-deoxy-3\u2019,5\u2019-di-O-isobutyryl-2\u2019-fluorocytidine (ALS-8176), a first-in-class RSV polymerase inhibitor for treatment of human respiratory syncytial virus infection","volume":"58","author":"Wang","year":"2015","journal-title":"J Med Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620302066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089620302066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:06:11Z","timestamp":1760835971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089620302066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0968089620302066"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115401","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational modifications, synthesis and biological evaluation of new potential antivirals for RSV designed to target the M2-1 protein","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2020.115401","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115401"}}